Now live: Pro — the full 13F research suite for serious investorsSee pricing →
JGP Global Gestao de Recursos Ltda.

Q2 2024 · 13F-HR

JGP Global Gestao de Recursos Ltda.holdings as filed

Filed 2024-08-02 · accession 0001536562-24-000006

$78.8M
Reported value
41
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G85158106STNESTONECO LTD-A$24.3M30.8%2,024,080CommonSOLE
G6683N103NUNU HOLDINGS LTD/CAYMAN ISL-A$15.8M20.1%1,229,300CommonSOLE
Y1436A102CHINA COMMUNICATIONS SERVI-H$12.6M16.0%3,000,000CommonSOLE
J11257102DSKYFDAIICHI SANKYO CO LTD$7.0M8.85%1,262CommonSOLE
78409V104SPGIS&P GLOBAL INC$2.2M2.83%5,000CommonSOLE
532457108LLYELI LILLY & CO$1.9M2.47%2,152CommonSOLE
45337C102INCYINCYTE CORP$1.9M2.42%31,434CommonSOLE
07725L102ONCBEIGENE LTD-ADR$1.5M1.90%10,464CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$1.2M1.55%2,401CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$784,7151.00%1,764CommonSOLE
883556102TMOTHERMO FISHER SCIENTIFIC INC$767,5640.97%1,388CommonSOLE
036752103ELVELEVANCE HEALTH INC$633,9760.80%1,170CommonSOLE
58933Y105MRKMERCK & CO. INC.$618,3810.78%4,995CommonSOLE
004225108ACADACADIA PHARMACEUTICALS INC$597,0250.76%36,740CommonSOLE
863667101SYKSTRYKER CORP$574,6820.73%1,689CommonSOLE
92532F100VRTXVERTEX PHARMACEUTICALS INC$490,2810.62%1,046CommonSOLE
235851102DHRDANAHER CORP$464,9710.59%1,861CommonSOLE
008474108AEMAGNICO-EAGLE MINES LTD$424,9040.54%6,497CommonSOLE
04016X101ARGXARGENX SE - ADR$381,4450.48%887CommonSOLE
53680V107LTHCFLITHIUM IONIC CORP$378,0210.48%713,247CommonSOLE
558868105MDGLMADRIGAL PHARMACEUTICALS INC$373,4530.47%1,333CommonSOLE
046353108AZNNASTRAZENECA PLC-SPONS ADR$361,1720.46%4,631CommonSOLE
30231G102XOMEXXON MOBIL CORP$352,9580.45%3,066CommonSOLE
09061G101BMRNBIOMARIN PHARMACEUTICAL INC$346,8560.44%4,213CommonSOLE
75886F107REGNREGENERON PHARMACEUTICALS$345,7890.44%329CommonSOLE
031162100AMGNAMGEN INC$327,4480.42%1,048CommonSOLE
02043Q107ALNYALNYLAM PHARMACEUTICALS INC$299,6190.38%1,233CommonSOLE
011532108AGIALAMOS GOLD INC-CLASS A$242,2870.31%15,452CommonSOLE
644535106NGDNNEW GOLD INC$240,8780.31%123,527CommonSOLE
76243J105RYTMRHYTHM PHARMACEUTICALS INC$238,7230.30%5,814CommonSOLE
670100205NVONOVO-NORDISK A/S-SPONS ADR$235,3780.30%1,649CommonSOLE
60855R100MOHMOLINA HEALTHCARE INC$228,6240.29%769CommonSOLE
125523100CICIGNA CORP$210,2430.27%636CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$106,0810.13%10,036CommonSOLE
09058V103BCRXBIOCRYST PHARMACEUTICALS INC$67,1460.09%10,865CommonSOLE
X84439102SPINNSPINNOVA OYJ$54,5420.07%34,089CommonSOLE
00288U106ABCLABCELLERA BIOLOGICS INC$52,6260.07%17,779CommonSOLE
50015M109KODKODIAK SCIENCES INC$35,1490.04%14,957CommonSOLE
157085101CERSCERUS CORP$25,5890.03%14,539CommonSOLE
670851500OI SA-ADR$1,4950.00%575,000CommonSOLE
80585Y308SBERSBERBANK PJSC - SPONSORED ADR$0160,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.